Cambridge Investment Research Advisors’s Gossamer Bio GOSS Stock Holding History

Cambridge Investment Research Advisors’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7K	Hold	535	–	–	﹤0.01%	4037
2026 Q1	$14K	Sell	535 -427	-44%	-$53.7K	﹤0.01%	3904
2025 Q4	$239K	Sell	962 -6	-0.6%	-$1.37K	﹤0.01%	3417
2025 Q3	$204K	Buy	968 +727	+302%	+$128K	﹤0.01%	3469
2025 Q2	$24K	Hold	241	–	–	﹤0.01%	3571
2025 Q1	$21K	Buy	241 +41	+21%	+$3.79K	﹤0.01%	3453
2024 Q4	$14K	Hold	200	–	–	﹤0.01%	3437
2024 Q3	$16K	Hold	200	–	–	﹤0.01%	3377
2024 Q2	$14K	Buy	200 +12	+6%	+$718	﹤0.01%	3280
2024 Q1	$18K	Buy	+188	New	+$16.6K	﹤0.01%	3266

Other funds holding GOSS

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

DIG

DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Cambridge Investment Research Advisors's GOSS Position: Q2 2026 in Review

Cambridge Investment Research Advisors held its Gossamer Bio (GOSS) position steady in Q2 2026 at 535 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #4037.

Cambridge Investment Research Advisors first reported a position in GOSS in Q1 2024 and has held it in 10 quarters since. The position peaked at $239K in Q4 2025. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

Cambridge Investment Research Advisors held 535 shares of Gossamer Bio worth $7K as of Q2 2026.
Cambridge Investment Research Advisors left its Gossamer Bio share count unchanged in Q2 2026.
Gossamer Bio made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #4037 holding.
Cambridge Investment Research Advisors first reported a position in Gossamer Bio in Q1 2024 and has held it in 10 quarters since.
Cambridge Investment Research Advisors's Gossamer Bio position peaked at $239K in Q4 2025.
166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.